{"id":"https://openalex.org/W4389464779","doi":"https://doi.org/10.1212/wnl.92.15_supplement.p4.6-001","title":"Clinical Characteristics of a Large Cohort of US Patients Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010\u20132015 (P4.6-001)","display_name":"Clinical Characteristics of a Large Cohort of US Patients Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010\u20132015 (P4.6-001)","publication_year":2019,"publication_date":"2019-04-09","ids":{"openalex":"https://openalex.org/W4389464779","doi":"https://doi.org/10.1212/wnl.92.15_supplement.p4.6-001"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.92.15_supplement.p4.6-001","doi":"https://doi.org/10.1212/wnl.92.15_supplement.p4.6-001","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.92.15_supplement.p4.6-001","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032748018","display_name":"Jaime S. Raymond","orcid":"https://orcid.org/0000-0002-5594-6931","observed_orcids":["https://orcid.org/0000-0002-5594-6931"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I199145359","display_name":"Agency for Toxic Substances and Disease Registry","ror":"https://ror.org/0045x2741","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I199145359"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaime Raymond","raw_affiliation_strings":["National ALS Registry, CDC/ATSDR Atlanta GA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National ALS Registry, CDC/ATSDR Atlanta GA United States","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I199145359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052581382","display_name":"Bj\u00f6rn Oskarsson","orcid":"https://orcid.org/0000-0002-1725-9866","observed_orcids":["https://orcid.org/0000-0002-1725-9866"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bjorn Oskarsson","raw_affiliation_strings":["Mayo Clinic Jacksonville FL United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Jacksonville FL United States","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009919573","display_name":"Paul Mehta","orcid":"https://orcid.org/0000-0002-0796-8861","observed_orcids":["https://orcid.org/0000-0002-0796-8861"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I199145359","display_name":"Agency for Toxic Substances and Disease Registry","ror":"https://ror.org/0045x2741","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I199145359"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Mehta","raw_affiliation_strings":["National ALS Registry, CDC/ATSDR Atlanta GA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National ALS Registry, CDC/ATSDR Atlanta GA United States","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I199145359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017916838","display_name":"Ted Larson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I199145359","display_name":"Agency for Toxic Substances and Disease Registry","ror":"https://ror.org/0045x2741","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I199145359"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ted Larson","raw_affiliation_strings":["National ALS Registry, CDC/ATSDR Atlanta GA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National ALS Registry, CDC/ATSDR Atlanta GA United States","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I199145359"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036633532","display_name":"D. Kevin Horton","orcid":"https://orcid.org/0000-0001-6214-6687","observed_orcids":["https://orcid.org/0000-0001-6214-6687"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I199145359","display_name":"Agency for Toxic Substances and Disease Registry","ror":"https://ror.org/0045x2741","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934","https://openalex.org/I199145359"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Kevin Horton","raw_affiliation_strings":["National ALS Registry, CDC/ATSDR Atlanta GA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National ALS Registry, CDC/ATSDR Atlanta GA United States","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I199145359"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.40978588,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"92","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10863","display_name":"Voice and Speech Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3616","display_name":"Speech and Hearing"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/clinical-characteristics","display_name":"clinical features","score":0.7940000295639038},{"id":"https://openalex.org/keywords/disease-variability","display_name":"disease variability","score":0.8930000066757202},{"id":"https://openalex.org/keywords/national-als-registry","display_name":"National ALS Registry","score":0.8360000252723694},{"id":"https://openalex.org/keywords/patient-cohort","display_name":"patient cohort","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.9645150303840637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.685721755027771},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6394304633140564},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.36847826838493347},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3213065266609192},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2343062162399292}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.92.15_supplement.p4.6-001","doi":"https://doi.org/10.1212/wnl.92.15_supplement.p4.6-001","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.92.15_supplement.p4.6-001","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2947632266","https://openalex.org/W2524391050","https://openalex.org/W2167661024","https://openalex.org/W2621817236","https://openalex.org/W3209025357","https://openalex.org/W6902382429","https://openalex.org/W1991142615","https://openalex.org/W2751244039","https://openalex.org/W4389369005","https://openalex.org/W2349250761"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"describe":[2],"the":[3,15,25,38,75,118,123],"clinical":[4,78,282],"characteristics":[5,92],"of":[6,10,40,52,95,100,107,140,156,176,181,247,262],"a":[7,33,244,304],"large":[8,245],"cohort":[9,246],"ALS":[11,17,71,182,239,270],"patients":[12,72,189,196,206,248],"enrolled":[13],"in":[14,24,62,243,254,268],"National":[16],"Registry":[18],"to":[19,85,104,109,225,275,292,331,337,344],"help":[20],"determine":[21,86],"disease":[22,35,63,87,255],"variability":[23],"US.":[26],"Background:":[27],"Amyotrophic":[28],"lateral":[29],"sclerosis":[30],"(ALS)":[31],"is":[32],"progressive":[34],"that":[36],"causes":[37],"degeneration":[39],"upper":[41],"and":[42,66,90,113,133,152,167,214,251,258],"motor":[43],"neurons.":[44],"While":[45],"death":[46],"typically":[47],"occurs":[48],"within":[49],"2\u20135":[50],"years":[51,131],"initial":[53,101,144],"symptoms":[54,159,240],"for":[55,284,300],"most":[56,201],"cases,":[57],"there":[58],"are":[59],"wide":[60],"variations":[61,253],"onset,":[64,88,96,147,256],"progression,":[65,89,257],"prognosis.":[67,259],"Design/Methods:":[68],"Data":[69],"from":[70,321],"who":[73,121],"completed":[74,122],"Registry\u2019s":[76],"online":[77],"survey":[79],"module":[80],"during":[81],"2010\u20132015":[82],"were":[83,126,129,223],"analyzed":[84],"prognostic":[91],"(e.g.,":[93],"site":[94],"associated":[97],"symptoms,":[98],"time":[99,106,172],"symptom":[102,263],"onset":[103,154,188,222,264],"diagnosis,":[105],"diagnosis":[108,180,194,250],"hospice":[110,226],"referral,":[111],"pharmacological":[112],"non-pharmacological":[114],"interventions).":[115],"Results:":[116],"Of":[117],"1,758":[119],"participants":[120,142],"survey,":[124],"60.9%":[125],"male,":[127],"62.1%":[128],"50\u201369":[130],"old,":[132],"95.5%":[134],"identified":[135],"as":[136],"white.":[137],"Approximately":[138],"72.0%":[139],"all":[141],"reported":[143],"limb":[145,187],"weakness":[146],"followed":[148],"by":[149,205],"bulbar":[150,198],"(22.1%),":[151],"trunk/global":[153,221],"(6.1%)":[155],"disease.":[157],"Other":[158],"ever":[160],"experienced":[161],"included":[162,207],"cramps":[163,178,191],"(56.7%),":[164],"fasciculations":[165],"(56.3%),":[166],"dysarthria":[168],"(33.0%).":[169],"The":[170,200],"median":[171],"between":[173],"an":[174],"increase":[175],"muscle":[177],"until":[179],"was":[183],"12":[184],"months;":[185],"however,":[186],"had":[190],"longer":[192],"preceding":[193,249],"versus":[195],"with":[197,220,312],"onset.":[199],"frequent":[202],"interventions":[203,278],"used":[204],"riluzole":[208],"(48.3%":[209],"currently":[210],"using),":[211],"wheelchairs/scooters":[212],"(32.8%),":[213],"noninvasive":[215],"breathing":[216],"equipment":[217],"(30.0%).":[218],"Patients":[219],"referred":[224],"almost":[227],"four":[228],"times":[229],"earlier":[230,276],"than":[231],"other":[232,310],"patients.":[233,285],"Conclusions:":[234],"These":[235],"data":[236],"show":[237],"how":[238],"differ":[241],"widely":[242],"reflect":[252],"Better":[260],"characterization":[261],"may":[265],"assist":[266],"neurologists":[267],"diagnosing":[269],"sooner,":[271],"which":[272],"could":[273],"lead":[274],"therapeutic":[277],"and/or":[279],"enrollment":[280],"into":[281],"trials":[283],"Disclosure:":[286],"Dr.":[287,294,315,327,333,339],"Raymond":[288],"MPH":[289],"has":[290,296,317,329,335,342],"nothing":[291,330,336,343],"disclose.":[293,332,338,345],"Oskarsson":[295,316],"received":[297,318],"personal":[298],"compensation":[299],"consulting,":[301],"serving":[302],"on":[303],"scientific":[305],"advisory":[306],"board,":[307],"speaking,":[308],"or":[309],"activities":[311],"Biogen,":[313],"FlexPharma.":[314],"research":[319],"support":[320],"Genentech,":[322],"Cytokinetics,":[323],"GlaxoSmithKline,":[324],"Astellas,":[325],"Neuraltus.":[326],"Mehta":[328],"Larson":[334],"Horton":[340],"DrPH":[341]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-08T00:00:00"}